- Home
- STOK vs SATL Comparison
STOK vs SATL Comparison
Compare STOK & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- SATL
- Stock Information
- Founded
- STOK 2014
- SATL 2010
- Country
- STOK United States
- SATL United States
- Employees
- STOK N/A
- SATL N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- SATL Radio And Television Broadcasting And Communications Equipment
- Sector
- STOK Health Care
- SATL Technology
- Exchange
- STOK Nasdaq
- SATL Nasdaq
- Market Cap
- STOK 517.0M
- SATL 433.8M
- IPO Year
- STOK 2019
- SATL N/A
- Fundamental
- Price
- STOK $9.36
- SATL $4.27
- Analyst Decision
- STOK Strong Buy
- SATL
- Analyst Count
- STOK 5
- SATL 0
- Target Price
- STOK $27.50
- SATL N/A
- AVG Volume (30 Days)
- STOK 813.9K
- SATL 905.1K
- Earning Date
- STOK 05-20-2025
- SATL 05-20-2025
- Dividend Yield
- STOK N/A
- SATL N/A
- EPS Growth
- STOK N/A
- SATL N/A
- EPS
- STOK N/A
- SATL N/A
- Revenue
- STOK $36,555,000.00
- SATL $12,870,000.00
- Revenue This Year
- STOK $27.80
- SATL N/A
- Revenue Next Year
- STOK $9.53
- SATL N/A
- P/E Ratio
- STOK N/A
- SATL N/A
- Revenue Growth
- STOK 316.34
- SATL 27.75
- 52 Week Low
- STOK $5.35
- SATL $0.72
- 52 Week High
- STOK $17.58
- SATL $5.49
- Technical
- Relative Strength Index (RSI)
- STOK 57.94
- SATL 55.38
- Support Level
- STOK $8.30
- SATL $3.96
- Resistance Level
- STOK $10.12
- SATL $4.86
- Average True Range (ATR)
- STOK 0.59
- SATL 0.38
- MACD
- STOK -0.03
- SATL 0.02
- Stochastic Oscillator
- STOK 58.24
- SATL 59.59
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.